SC 13G
IOVANCE BIOTHERAPEUTICS, INC.
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Filed
- February 17, 2023
- Accession Number
- 0000902664-23-001919
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →